CD4+ T cells derived from the blood of MS patients are relatively hyporesponsive to the immunosuppressive function of IL-10 in vitro compared to healthy controls, and this hyporesponsiveness is associated with impaired STAT3 phosphorylation (77), suggesting defects in IL-10Rα signaling. Here, CD4 is linked to myeloid sarcoma.